|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
Carboquone
|
MedKoo Code#: 100133
|
|
Name:
Carboquone
|
|
CAS#: 24279-91-2
Synonym: carbazilquinone.
{2-[2,5-bis(aziridin-1-yl)-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-2-methoxyethyl}
carbamate.
IUPAC/Chemical name:
2-(2,5-di(aziridin-1-yl)-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-methoxyethyl
carbamate
|
|
Chemical structure:
|
Theoretical analysis
:
|
|

|
Chemical Formula: C15H19N3O5
Exact Mass: 321.13247
Molecular Weight: 321.33
m/z: 321.13247 (100.0%), 322.13583 (16.2%),
323.13918 (1.2%), 322.12951 (1.1%), 323.13672 (1.0%)
Elemental Analysis: C, 56.07; H, 5.96; N,
13.08; O, 24.90
|
|
Availability and price
This agent is
available through our partner. For quotation, question, and order, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer significant discount
for larger quantity order.
|
|
Quality control
data:
Product will be shipped with
supporting analytical data.
|
|
Information about this agent
|
Carboquone is an antineoplastic in the class of alkylating agents
and is used to treat various forms of cancer. Alkylating agents are
so named because of their ability to add alkyl groups to many
electronegative groups under conditions present in cells. They stop
tumor growth by cross-linking guanine bases in DNA double-helix
strands - directly attacking DNA. This makes the strands unable to
uncoil and separate. As this is necessary in DNA replication, the
cells can no longer divide. In addition, these drugs add methyl or
other alkyl groups onto molecules where they do not belong which in
turn inhibits their correct utilization by base pairing and causes a
miscoding of DNA. Alkylating agents are cell cycle-nonspecific.
Alkylating agents work by three different mechanisms all of which
achieve the same end result - disruption of DNA function and cell
death.
1: Bolboacă SD, Jäntschi L. Comparison
of quantitative structure-activity relationship model performances on
carboquinone derivatives. ScientificWorldJournal. 2009 Oct 14;9:1148-66.
PubMed PMID: 19838601.
2: Suzuki Y, Takagi R, Kawasaki I, Matsudaira T, Yanagisawa H, Shimizu
H. The micronucleus test and erythropoiesis: effects of cyclic adenosine
monophosphate (cAMP) on micronucleus formation. Mutat Res. 2008
Aug-Sep;655(1-2):47-51. PubMed PMID: 18621143.
3: Morimoto K, Koh M. [Postoperative changes in serum lipid levels of
breast cancer and adjuvant chemotherapy]. Gan To Kagaku Ryoho. 2004
Oct;31(10):1517-24. Japanese. PubMed PMID: 15508443.
4: Kawakami J, Hoshi K, Ishiyama A, Miyagishima S, Sato K. Application
of a self-organizing map to quantitative structure-activity relationship
analysis of carboquinone and benzodiazepine. Chem Pharm Bull (Tokyo).
2004 Jun;52(6):751-5. PubMed PMID: 15187400.
5: Morimoto K, Koh M. Postoperative adjuvant use of carmofur for early
breast cancer. Osaka City Med J. 2003 Dec;49(2):77-83. PubMed PMID:
15179836.
6: Hargreaves RH, Hartley JA, Butler J. Mechanisms of action of quinone-containing
alkylating agents: DNA alkylation by aziridinylquinones. Front Biosci.
2000 Nov 1;5:E172-80. Review. PubMed PMID: 11056081.
7: Begleiter A. Clinical applications of quinone-containing alkylating
agents. Front Biosci. 2000 Nov 1;5:E153-71. Review. PubMed PMID:
11056078.
8: Tabata M, Imagawa S, Tarumoto T, Ohmine K, Hatake K, Miura Y, Ozawa
K. Essential thrombocythemia transformed to acute myelogenous leukemia
with t(3;17)(p24; q12), del(5)(q13q34) after treatment with carboquone
and hydroxyurea. Jpn J Clin Oncol. 2000 Jul;30(7):310-2. PubMed PMID:
11007164.
9: Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H. Anticancer
chemosensitivity profiles of human breast cancer cells assessed by in
vitro DNA synthesis inhibition assay. Anticancer Res. 2000
Mar-Apr;20(2B):1237-44. PubMed PMID: 10810427.
10: Higuchi T, Oba R, Endo M, Harada H, Mori H, Niikura H, Omine M,
Fujita K. Transition of polycythemia vera to chronic neutrophilic
leukemia. Leuk Lymphoma. 1999 Mar;33(1-2):203-6. Review. PubMed PMID:
10194140.
11: Gough JD, Hall LH. Modeling antileukemic activity of carboquinones
with electrotopological state and chi indices. J Chem Inf Comput Sci.
1999 Mar-Apr;39(2):356-61. PubMed PMID: 10192947.
12: Naoe Y, Inami M, Kawamura I, Nishigaki F, Tsujimoto S, Matsumoto S,
Manda T, Shimomura K. Cytotoxic mechanisms of FK317, a new class of
bioreductive agent with potent antitumor activity. Jpn J Cancer Res.
1998 Jun;89(6):666-72. PubMed PMID: 9703365.
13: Kawabata K, Nio Y, Imamura M, Fukumoto M. Anticancer
chemosensitivity and growth rate of freshly separated human colorectal
cancer cells assessed by in vitro DNA synthesis inhibition assay.
Anticancer Res. 1998 May-Jun;18(3A):1633-40. PubMed PMID: 9673382.
14: Kawabata K, Nio Y, Imamura M. 5-Fluorouracil + cisplatin + mitomycin
C is a relatively most effective combination against xenograft lines of
human colorectal cancer. Anticancer Drugs. 1997 Sep;8(8):790-6. PubMed
PMID: 9396624.
15: Takeuchi H, Baba H, Inutsuka S, Maehara Y, Sugimachi K. Potentiation
of the cytotoxicity of carboquone by flavone acetic acid combined with
hyperthermia. Anticancer Drugs. 1997 Sep;8(8):778-83. PubMed PMID:
9396622.
16: Takenaka T, Maruyama K, Kinoshita T, Sasako M, Sano T, Katai H,
Matsuno Y. A prospective study of surgery and adjuvant chemotherapy for
primary gastric lymphoma stage II. Br J Cancer. 1997;76(11):1484-8.
PubMed PMID: 9400946; PubMed Central PMCID: PMC2228181.
17: Morgan WA, Prins B, Koster AS. Relationship between acute toxicity
of (bis)aziridinylbenzoquinones and cellular pyridine nucleotides. Arch
Toxicol. 1997;71(9):582-7. PubMed PMID: 9285041.
18: Sakata Y, Takemori H, Suzuki H. [Chemotherapy for pancreatic
cancer]. Gan To Kagaku Ryoho. 1996 Oct;23(12):1647-50. Review. Japanese.
PubMed PMID: 8886035.
19: Matano S, Nakamura S, Kobayashi K, Kaya H, Yoshida T, Sugimoto T.
[Low-dose combination cytarabine and etoposide for myeloid crisis
transformed from unclassified chronic myeloproliferative disorder]. Gan
To Kagaku Ryoho. 1996 Jul;23(8):1055-8. Japanese. PubMed PMID: 8687221.
20: Ito H. [Experimental study and clinical application of a new
combination chemotherapy with cis-platinum, adriamycin and carboquone in
patients with advanced prostate cancer]. Nippon Ika Daigaku Zasshi. 1995
Oct;62(5):456-68. Japanese. PubMed PMID: 7499463.
21: Mäenpää JU, Heinonen E, Hinkka SM, Karnani P, Klemi PJ, Korpijaakko
TA, Kuoppala TA, Laine AM, Lähde MA, Nuoranne EK, et al. The subrenal
capsule assay in selecting chemotherapy for ovarian cancer: a
prospective randomized trial. Gynecol Oncol. 1995 Jun;57(3):294-8.
PubMed PMID: 7774832.
22: Shibata K, Kasahara K, Bando T, Nakatsumi Y, Fujimura M, Tsuruo T,
Matsuda T. Establishment and characterization of non-small cell lung
cancer cell lines resistant to mitomycin C under aerobic conditions. Jpn
J Cancer Res. 1995 May;86(5):460-9. PubMed PMID: 7790319.
23: Higuchi T, Okada S, Mori H, Niikura H, Omine M, Terada H. Leukemic
transformation of polycythemia vera and essential thrombocythemia
possibly associated with an alkylating agent. Cancer. 1995 Jan
15;75(2):471-7. PubMed PMID: 7812918.
24: Miyagi M, Soda T, Nakashima T. [Flow cytometric DNA analysis and
chemosensitivity in squamous cell carcinoma of the head and neck].
Nippon Jibiinkoka Gakkai Kaiho. 1994 Dec;97(12):2247-58. Japanese.
PubMed PMID: 7861297.
25: Masai Y, Nio Y, Tsubono M, Tseng CC, Kawabata K, Hayashi H, Ishigami
S, Imamura M. Anticancer chemosensitivity profile of freshly separated
human pancreatic cancer cells assessed by DNA synthesis inhibition
assay. J Surg Oncol. 1994 Oct;57(2):97-104. PubMed PMID: 7934070.
26: Okuyama T, Maehara Y, Endo K, Baba H, Adachi Y, Kuwano M, Sugimachi
K. Expression of glutathione S-transferase-pi and sensitivity of human
gastric cancer cells to cisplatin. Cancer. 1994 Aug 15;74(4):1230-6.
PubMed PMID: 8055443.
27: Emi Y, Maehara Y, Kusumoto T, Baba H, Takahashi I, Yoshida M,
Sugimachi K. Hydralazine combined with hyperthermia enhances the effects
of carboquone. Oncology. 1994 Jul-Aug;51(4):339-43. PubMed PMID:
8208517.
28: Baba H, Takeuchi H, Inutsuka S, Yamamoto M, Endo K, Ohno S, Maehara
Y, Sugimachi K. Clinical value of SDI test for predicting effect of
postoperative chemotherapy for patients with gastric cancer. Semin Surg
Oncol. 1994 Mar-Apr;10(2):140-4. PubMed PMID: 8052784.
29: Takeuchi H, Baba H, Inutsuka S, Takahashi I, Kusumoto H, Maehara Y,
Sugimachi K. Antitumor chemosensitivity differs between clinical sarcoma
and adenocarcinoma tissues. Anticancer Res. 1994 Jan-Feb;14(1A):169-71.
PubMed PMID: 8166444.
30: Sampi K, Makishima M, Kuga T, Yanagawa S, Hattori M. [Intensive
1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-
nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone
marrow transplantation]. Gan To Kagaku Ryoho. 1993 Oct;20(13):1989-93.
Japanese. PubMed PMID: 8215473.
31: Yoh S, Isayama T, Yoshitake K, Johzima H, Ikari N, Ogata K.
[Post-operative intra-arterial chemotherapy for high grade malignant
musculoskeletal sarcoma]. Gan To Kagaku Ryoho. 1993 Aug;20(11):1682-5.
Japanese. PubMed PMID: 8373248.
32: Harada Y, Katano T, Nakamura Y, Adachi Y. [A case of chronic
neutrophilic leukemia associated with polycythemia vera]. Rinsho
Ketsueki. 1993 Jun;34(6):738-42. Review. Japanese. PubMed PMID: 8366577.
33: Tetko IV, Luik AI, Poda GI. Applications of neural networks in
structure-activity relationships of a small number of molecules. J Med
Chem. 1993 Apr 2;36(7):811-4. PubMed PMID: 8464034.
34: Adachi A, Hayashi A, Hayashida R, Hattori R, Nagamatsu Y, Nasu K,
Iwanaga D, Takagi K, Ono H, Kakegawa T. [Preoperative chemotherapy in
patients with non-small cell lung cancer]. Gan To Kagaku Ryoho. 1993
Apr;20(5):673-5. Japanese. PubMed PMID: 8385907.
35: Ichikawa H, Aoyama T. How to see characteristics of structural
parameters in QSAR analysis: descriptor mapping using neural networks.
SAR QSAR Environ Res. 1993;1(2-3):115-30. PubMed PMID: 8790628.
36: Mäenpää JU, Heinonen E, Karnani P, Kauppila A, Kuoppala T, Salmi T,
Sipilä P, Nieminen U. Carboquone combined with methotrexate and
5-fluorouracil for recurrent and advanced ovarian cancer. Eur J Cancer.
1993;29A(11):1633. PubMed PMID: 8217372.
37: Yonekura S, Nagao T, Arimori S. Essential thrombocythemia developing
into refractory anemia and complicated by acute myeloid leukemia. Intern
Med. 1992 Oct;31(10):1224-7. PubMed PMID: 1286233.
38: Takamori S, Tsushimi M, Onaka A, Nakarai I. [A case of hyperosmolar
nonketotic coma occurring during chemotherapy in lung cancer]. Gan To
Kagaku Ryoho. 1992 Sep;19(11):1919-22. Japanese. PubMed PMID: 1325754.
39: Yamagata M, Kanematsu T, Matsumata T, Utsunomiya T, Ikeda Y,
Sugimachi K. The difference in chemosensitivity to antineoplastic agents
of human hepatocellular carcinoma cells under normo-oxygenated or
hypoxic conditions. Eur J Surg Oncol. 1992 Aug;18(4):379-82. PubMed
PMID: 1325926.
40: Fushiki H. [Characterization of two novel cell lines established
from a single human uterine cervical adenocarcinoma, and their
chemosensitivities and hormonal effects on their proliferation]. Nippon
Sanka Fujinka Gakkai Zasshi. 1992 Apr;44(4):397-404. Japanese. PubMed
PMID: 1607768.
41: Akimoto Y, Ishiyama T, Sano M, Ueno H, Nakamaki T, Hino K, Tomoyasu
S, Tsuruoka N. [Essential thrombocythemia that transformed to
myelofibrosis after three years]. Rinsho Ketsueki. 1992 Apr;33(4):520-4.
Japanese. PubMed PMID: 1602618.
42: Hino K, Sato S, Sakashita A, Tomoyasu S, Tsuruoka N, Koike T. [Megakaryoblastic
transformation associated with disseminated intravascular coagulation in
the course of polycythemia vera: a case report]. Rinsho Ketsueki. 1992
Apr;33(4):500-6. Review. Japanese. PubMed PMID: 1602615.
43: Katayama T, Masuoka H, Yoshida M, Watanabe R, Nishiwaki K, Shimada
T, Kaito K, Ochiai S, Kobayashi M, Sakai O. [Successful low-dose
etoposide therapy for a case of myelofibrosis with chronic myelogenous
leukemia megakaryocytic predominance type]. Rinsho Ketsueki. 1992
Apr;33(4):488-93. Japanese. PubMed PMID: 1602613.
44: Sakaguchi Y, Anai H, Kohnoe S, Emi Y, Kusumoto T, Maehara Y,
Sugimachi K. Resistance to anticancer drugs of well differentiated
gastric adenocarcinoma with venous invasion. Eur J Surg Oncol. 1992
Apr;18(2):142-5. PubMed PMID: 1582507.
45: Sampi K, Kuga T, Makishima M, Hattori M. [Intensive carboquone and
cryopreserved autologous bone marrow transplantation for relapsed
malignancies]. Gan To Kagaku Ryoho. 1992 Feb;19(2):257-9. Japanese.
PubMed PMID: 1736840.
46: Kusumoto H, Maehara Y, Yoshida M, Takahashi I, Anai H, Sugimachi K.
Relationship between tumor histopathology and in vitro sensitivity to
antitumor drugs in gastric cancer. Anticancer Drugs. 1992 Feb;3(1):33-8.
PubMed PMID: 1623213.
47: Saito A, Korenaga D, Maehara Y, Baba H, Okamura T, Sugimachi K. In
vitro succinate dehydrogenase chemosensitivity of gastric
carcinoma--relationship to DNA content. Cancer Chemother Pharmacol.
1992;29(3):185-9. PubMed PMID: 1733550.
48: Okada J, Masuyama Y, Kondo T. An analysis of first-order release
kinetics from albumin microspheres. J Microencapsul. 1992
Jan-Mar;9(1):9-18. PubMed PMID: 1613648.
49: Kusumoto T, Sakaguchi Y, Maehara Y, Nakashima T, Furusawa M,
Sugimachi K. Comparison of in vitro anticancer chemosensitivity between
human squamous cell carcinoma and adenocarcinoma. Oncology.
1992;49(5):343-6. PubMed PMID: 1528569.
50: Sakaguchi Y, Kohnoe S, Emi Y, Maehara Y, Kusumoto T, Sugimachi K.
Cytotoxicity of mitomycin C and carboquone combined with hyperthermia
against hypoxic tumor cells in vitro. Oncology. 1992;49(3):227-32.
PubMed PMID: 1495751.
51: Nio Y, Tseng CC, Tsubono M, Kawabata K, Masai Y, Shiraishi T,
Fukumoto M, Tobe T. Combining independently effective anticancer agents
may not augment the independent antitumor effects: a study using human
digestive organ cancer xenograft lines in nude mice. J Surg Oncol. 1991
Dec;48(4):252-9. PubMed PMID: 1745050.
52: Tsushima K, Sakata Y, Shiratori Y, Sakamoto J, Koeda J, Yamada Y,
Soma N, Tamura K, Yoshiwara A, Soma Y, et al. [Cases of advanced
cholangiocarcinoma showing partial response by the combination
chemotherapy including protracted continuous infusion of 5-FU combined
with intravenous administration of low-dose leucovorin and
intra-arterial administration of MMC and CQ]. Gan To Kagaku Ryoho. 1991
Dec;18(15):2603-5. Japanese. PubMed PMID: 1660702.
53: Fujita H. [Clinical pharmacology of anticancer agents. (Part 1)
Introduction, alkylating agents and platinum compounds]. Gan To Kagaku
Ryoho. 1991 Nov;18(14):2481-7. Japanese. PubMed PMID: 1952967.
54: Okada J, Asano S, Kondo T. A new concept for interpretation of
first-order release from albumin microspheres. J Microencapsul. 1991
Oct-Dec;8(4):483-96. PubMed PMID: 1798019.
55: Miyoshi Y, Okada S, Takizawa Y, Hagiwara S, Mori H, Niikura H,
Terada H, Fujita K. [Acute megakaryoblastic leukemia developing 11 years
after diagnosis of essential thrombocythemia]. Rinsho Ketsueki. 1991
Aug;32(8):868-73. Review. Japanese. PubMed PMID: 1942527.
56: Kusumoto T, Maehara Y, Sakaguchi Y, Kohnoe S, Emi Y, Sugimachi K.
Sarcoma-180 cells and human colorectal tumor cells under in vitro
hypoxic conditions are more sensitive to mitomycin C and carboquone. Eur
J Surg Oncol. 1991 Aug;17(4):358-63. PubMed PMID: 1908390.
57: Ohyama S, Yonemura Y, Kinoshita K, Ninomiya I, Tugawa K, Kimura H,
Miyazaki I, Tanaka M, Endo Y, Sasaki T. [Chemosensitivity test for
gastric cancer by in vitro MTT assay]. Gan To Kagaku Ryoho. 1991
Aug;18(10):1593-7. Japanese. PubMed PMID: 1908213.
58: Ikeda K, Niwa N, Oka F, Ito H, Abe H, Nakagami Y. [A case of
advanced prostatic cancer presenting as inguinal mass]. Hinyokika Kiyo.
1991 Jul;37(7):765-7. Japanese. PubMed PMID: 1927782.
59: Kohnoe S, Emi Y, Takahashi I, Yoshida M, Maehara Y, Sugimachi K.
Hypoxia and acidity increase the cytotoxicity of mitomycin C and
carboquone to human tumor cells in vitro. Anticancer Res. 1991
Jul-Aug;11(4):1401-4. PubMed PMID: 1746896.
60: Kido Y, Mitsudomi T, Kuwano H, Maehara Y, Sugimachi K. Different
chemosensitivities of rat 3Y1 fibroblasts transformed by various agents
in vitro. Anticancer Res. 1991 May-Jun;11(3):1305-8. PubMed PMID:
1888164.
61: Kohnoe S, Emi Y, Sakaguchi Y, Maehara Y, Kusumoto T, Sugimachi K.
The microtiter SDI test is more advantageous than the SDI test for
assessing the chemosensitivity of human tumor cells. Anticancer Drugs.
1991 Apr;2(2):145-52. PubMed PMID: 1958859.
62: Imai S, Nio Y, Shiraishi T, Manabe T, Tobe T. In vivo inhibitory
effect of anticancer agents on human pancreatic cancer xenografts
transplanted in nude mice. Anticancer Res. 1991 Mar-Apr;11(2):657-64.
PubMed PMID: 2064319.
63: Nakayama T, Nakai Y, Tamura H, Nagano T, Shibamoto T, Ohara A, Ozawa
M, Kurata A. [A case of granulosa cell tumor with unusual histologic
features]. Nippon Sanka Fujinka Gakkai Zasshi. 1991 Mar;43(3):367-70.
Japanese. PubMed PMID: 1904472.
64: Sato K, Horiuchi M, Yo R, Nakarai I. [A long survival case of small
cell lung cancer synchronized with renal cancer]. Kyobu Geka. 1991
Mar;44(3):251-3. Japanese. PubMed PMID: 1850490.
65: Kohnoe S, Moriguchi S, Emi Y, Sakaguchi Y, Maehara Y, Ishida T,
Mitsudomi T, Sugimachi K. Lung adenocarcinoma is more sensitive than
gastric adenocarcinoma to anticancer drugs in vitro. Eur J Surg Oncol.
1991 Feb;17(1):47-50. PubMed PMID: 1995357.
66: Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N,
Fujimoto S, Tsukagoshi S, Taguchi T. [Cross-resistance of HO-221 and
various antitumor agents in sublines of mouse leukemia]. Gan To Kagaku
Ryoho. 1991 Feb;18(2):201-9. Japanese. PubMed PMID: 1899547.
67: Ueo H, Maehara Y, Saito A, Sakaguchi Y, Kohnoe S, Sugimachi K. Human
colon cancer tissues are more sensitive than rectal cancer tissues to
antitumor drugs in vitro. Oncology. 1991;48(2):158-61. PubMed PMID:
1997940.
68: Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N,
Fujimoto S, Tsukagoshi S, Taguchi T. Antitumor activity on murine tumors
of a novel antitumor benzoylphenylurea derivative, HO-221. Cancer
Chemother Pharmacol. 1991;28(5):351-6. PubMed PMID: 1914078.
69: Kanematsu T, Maehara Y, Matsumata T, Shirabe K, Akazawa K, Sugimachi
K. Human hepatocellular carcinoma sensitivity to antitumor drugs assayed
using the succinate dehydrogenase inhibition test. Oncology.
1991;48(1):34-8. PubMed PMID: 1846232.
70: Kondo T, Sakamoto J, Nakazato H. Alternating immunochemotherapy of
advanced gastric carcinoma: a randomized comparison of carbazilquinone
and PSK to carbazilquinone in patients with curative gastric resection.
Biotherapy. 1991;3(4):287-95. PubMed PMID: 1786194.
71: Hasuda K, Kobayashi H, Taniguchi S, Baba T. Increased therapeutic
efficacy of intra-arterial carboquone chemotherapy on a limb tumor in
rats, by using an acidic vehicle adjusted with lactate. Cancer Lett.
1990 Nov 5;54(3):133-7. PubMed PMID: 2224841.
72: Miyamoto K, Fukuchi K. [The sensitivity of 1,000 human tumors to
antitumor drugs using the succinate dehydrogenase inhibition (SDI)
test]. Rinsho Byori. 1990 Nov;38(11):1273-8. Japanese. PubMed PMID:
2273570.
73: Yagi S, Hashiguchi K, Nakajima M, Umeki S, Hara H, Soejima R. [A
case of polycythemia vera associated with idiopathic interstitial
pneumonia successfully treated by alkylating agents]. Nihon Kyobu
Shikkan Gakkai Zasshi. 1990 Oct;28(10):1366-71. Japanese. PubMed PMID:
2273667.
74: Nakashima T, Maehara Y, Kohnoe S, Hayashi I, Katsuta Y. Histologic
differentiation and chemosensitivity of human head and neck squamous
cell carcinomas. Head Neck. 1990 Sep-Oct;12(5):406-10. PubMed PMID:
2211101.
75: Aoyama T, Suzuki Y, Ichikawa H. Neural networks applied to
quantitative structure-activity relationship analysis. J Med Chem. 1990
Sep;33(9):2583-90. Review. PubMed PMID: 2202830.
76: Mitsudomi T, Kaneko S, Tateishi M, Yano T, Ishida T, Kohnoe S,
Maehara Y, Sugimachi K. Chemosensitivity testing of human lung cancer
tissues using the succinate dehydrogenase inhibition test. Anticancer
Res. 1990 Jul-Aug;10(4):987-90. PubMed PMID: 2382998.
77: Maehara Y, Sakaguchi Y, Emi Y, Kusumoto T, Kohnoe S, Mori M,
Sugimachi K. Primary and metastatic liver lesions of clinical colorectal
cancer differ in chemosensitivity. Int J Colorectal Dis. 1990
May;5(2):87-9. PubMed PMID: 2358741.
78: Sekiguchi I, Suzuki M, Aida I, Tamada T, Nishida M. [Responsiveness
of gynecological malignancies to oral antitumor agents in subrenal
capsule assay and individualization of oral adjuvant chemotherapy].
Nippon Sanka Fujinka Gakkai Zasshi. 1990 May;42(5):437-42. Japanese.
PubMed PMID: 2115558.
79: Kudoh S, Komiyama S, Miyazaki H, Matsui K. Appearance of
drug-resistant tumor cells in a maxillary cancer patient undergoing
chemotherapy and chemoradiotherapy. Am J Otolaryngol. 1990
May-Jun;11(3):165-9. PubMed PMID: 1696435.
80: Lin ST. [Study on chemosensitivity test (in vitro) of cultured human
urogenital carcinoma cell lines by MTT assay]. Nippon Ika Daigaku Zasshi.
1990 Apr;57(2):127-36. Japanese. PubMed PMID: 1694861.
81: Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
Chemosensitivity correlation between the primary tumors and simultaneous
metastatic lymph nodes of patients evaluated by DNA synthesis inhibition
assay. Cancer. 1990 Mar 15;65(6):1273-8. PubMed PMID: 2106383.
82: Ueda G, Abe Y, Yoshida M, Fujiwara T. Embryonal carcinoma of the
ovary: a six-year survival. Int J Gynaecol Obstet. 1990
Mar;31(3):287-92. PubMed PMID: 1690671.
83: Nakao I, Ohashi Y, Ito K, Yokoyama T, Nishi I, Kanko T, Saito T.
[Combination chemotherapy of non-small cell lung cancer (NSCLC) with
cisplatin (CDDP), carboquone (CQ) and prednisolone (PDN)(PPQ therapy)].
Gan To Kagaku Ryoho. 1990 Feb;17(2):217-20. Japanese. PubMed PMID:
2154159.
84: Maehara Y, Emi Y, Sakaguchi Y, Kusumoto T, Kakeji Y, Kohnoe S,
Sugimachi K. Estrogen-receptor-negative breast cancer tissue is
chemosensitive in vitro compared with estrogen-receptor-positive tissue.
Eur Surg Res. 1990;22(1):50-5. PubMed PMID: 2379525.
85: Maehara Y, Anai H, Sakaguchi Y, Kusumoto T, Emi Y, Sugimachi K.
Detection of DNA strand breaks in HeLa cells in vitro and in mouse
sarcoma 180 cells in vivo induced by an alkylating agent, carboquone,
using in situ nick translation. Oncology. 1990;47(3):282-6. PubMed PMID:
2342771.
86: Kimura S, Uoshima N, Tanaka R, Kobayashi Y, Ozawa M, Maruo N, Kondo
M, Abe T, Yoshida Y. [Polycythemia vera terminating in myelodysplastic
syndrome]. Rinsho Ketsueki. 1990 Jan;31(1):100-4. Japanese. PubMed PMID:
2313900.
87: Watanabe Y, Shimizu J, Murakami S, Yoshida M, Tsubota M, Iwa T,
Kitagawa M, Mizukami Y, Nonomura A, Matsubara F. Reappraisal of
bronchial arterial infusion therapy for advanced lung cancer. Jpn J
Surg. 1990 Jan;20(1):27-35. PubMed PMID: 2154638.
88: Mizuno K, Furuhashi Y, Maeda O, Iwata M, Misawa T, Kawai M, Kano T,
Tomoda Y. Mitomycin C cross-resistance induced by adriamycin in human
ovarian cancer cells in vitro. Cancer Chemother Pharmacol.
1990;26(5):333-9. PubMed PMID: 1976451.
89: Lusthof KJ, De Mol NJ, Janssen LH, Egberink RJ, Verboom W, Reinhoudt
DN. Covalent binding studies on the 14C-labeled antitumor compound
2,5-bis(1-aziridinyl)-1,4-benzoquinone. Involvement of semiquinone
radical in binding to DNA, and binding to proteins and bacterial
macromolecules in situ. Chem Biol Interact. 1990;76(2):193-209. PubMed
PMID: 1699678.
90: Maehara Y, Anai H, Kusumoto T, Sakaguchi Y, Emi Y, Kohnoe S,
Sugimachi K. [Detection of cellular DNA strand breaks induced by
antitumor drug and heat using in situ nick translation]. Nippon Geka
Gakkai Zasshi. 1989 Sep;90(9):1576-8. Japanese. PubMed PMID: 2586469.
91: Yoh S, Arinaga M, Takagishi N, Isayama T, Soejima O, Fukabori Y,
Yoshitake K, Izaki T. [Post-operative intra-arterial chemotherapy in
patients with malignant bone and soft tissue tumors]. Gan To Kagaku
Ryoho. 1989 Aug;16(8 Pt 2):2718-21. Japanese. PubMed PMID: 2782883.
92: Watanabe T, Morimoto S, Shinka T, Kawabata M, Satoh M, Yamada R.
[Therapeutic embolization of renal angiomyolipoma: a case report].
Hinyokika Kiyo. 1989 Jul;35(7):1183-7. Japanese. PubMed PMID: 2801411.
93: Nio Y, Imai S, Shiraishi T, Ohgaki K, Tobe T. Lymphocytes anticancer
chemosensitivity testing in vitro--an approach to predict
immunosuppressive effect of anticancer agents. J Clin Lab Immunol. 1989
Jul;29(3):141-5. PubMed PMID: 2517429.
94: Nakao I. [Adverse reactions to carcinostatics and countermeasures].
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1099-107. Japanese. PubMed
PMID: 2499262.
95: Akashi M, Sakamoto S, Ohta M, Kitagawa S, Yoshida M, Saito M, Takaku
F, Miura Y. Treatment of multiple myeloma with carboquone-prednisolone.
Eur J Haematol. 1989 Mar;42(3):265-9. PubMed PMID: 2924889.
96: Sekino Y, Suzuki Y, Sato N, Sadahiro M, Mohri H. [Open-heart surgery
in a patient with chronic leukemia]. Nippon Geka Gakkai Zasshi. 1989
Mar;90(3):450-3. Japanese. PubMed PMID: 2770688.
97: Tsunoda S, Sasaki R, Miwa A, Sakurabayashi I, Miura Y. [Coma,
hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient
with IgG, lambda type multiple myeloma]. Rinsho Ketsueki. 1989
Mar;30(3):361-5. Japanese. PubMed PMID: 2504973.
98: Kobayashi K, Hino M, Kurane S, Yano T, Niitani H, Yamano Y, Hasegawa
K, Tuboi E. [A comparative randomized phase II study of CDDP, CDDP-carboquone
(CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung
cancer (SCLC)]. Gan To Kagaku Ryoho. 1989 Feb;16(2):207-12. Japanese.
PubMed PMID: 2537605.
99: Maehara Y, Kusumoto H, Kusumoto T, Anai H, Sugimachi K. Tumor tissue
is more sensitive to mitomycin C, carboquone, and aclacinomycin A than
is adjacent normal tissue in vitro. J Surg Oncol. 1989 Jan;40(1):4-7.
PubMed PMID: 2909804.
100: Sakata Y, Komatsu Y, Takagi S, Saitoh S, Itoh T, Suzuki H, Tsushima
K, Sasaki D, Yoshida Y. Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432
(MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM)
therapy against advanced liver cancer. Cancer Chemother Pharmacol.
1989;23 Suppl:S9-12. PubMed PMID: 2647315.
101: Sampi K, Masaoka T, Takagi T, Sakamoto S, Mikuni C, Kano Y. [Aclarubicin-combined
combination chemotherapy in patients with refractory or relapsed
non-Hodgkin's lymphoma]. Gan To Kagaku Ryoho. 1989 Jan;16(1):79-82.
Japanese. PubMed PMID: 2643395.
102: Kusumoto T, Maehara Y, Sakaguchi Y, Saku M, Sugimachi K. Hypoxia
enhances the lethality of mitomycin C and carboquone against human
malignant tumor cells in vitro. Eur Surg Res. 1989;21(3-4):224-31.
PubMed PMID: 2509206.
103: Kusumoto H, Maehara Y, Kusumoto T, Anai H, Akazawa K, Sugimachi K.
Chemosensitivity differences between primary and metastatic lesions of
clinical gastric cancer. Eur J Surg Oncol. 1988 Dec;14(6):685-9. PubMed
PMID: 3192005.
104: Akashi M, Ohta M, Kitagawa S, Furukawa Y, Takeda K, Muroi K,
Komatsu N, Ikeda K, Ohsaka A, Yoshida M, et al. [Treatment of multiple
myeloma: renal function in relation to its prognosis]. Rinsho Ketsueki.
1988 Nov;29(11):1991-7. Japanese. PubMed PMID: 3236408.
105: Sakata Y, Fukushi G, Tsushima K, Suzuki H, Kimura T, Kimura M,
Tamura Y, Kishibe T, Saitoh S, Itoh T, et al. [MQF-FT and MQF-UFT in
gallbladder and bile duct cancer]. Gan To Kagaku Ryoho. 1988
Sep;15(9):2731-5. Japanese. PubMed PMID: 3137889.
106: Kanematsu T, Maehara Y, Kusumoto T, Sugimachi K. Sensitivity to six
antitumor drugs differs between primary and metastatic liver cancers.
Eur J Cancer Clin Oncol. 1988 Sep;24(9):1511-3. PubMed PMID: 2846313.
107: Nasu K, Nakarai I, Horiuchi M, Shinoda A. [Clinical study of
combination chemotherapy using carboquone, cisplatin, UFT and OK-432 in
7 cases of advanced gastric cancers and a relapsed gastric cancer]. Gan
To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2410-3. Japanese. PubMed PMID:
3137878.
108: Sakata Y, Munakata A, Baba T, Saitoh S, Itoh T, Tamura Y,
Furukohori N, Suzuki H, Kimura T, Kawata K, et al. [Controlled study of
MQF-OK therapy with FT and with UFT on various advanced gastrointestinal
cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy]. Gan
To Kagaku Ryoho. 1988 Jul;15(7):2065-71. Japanese. PubMed PMID: 3134859.
109: Saito T. [An anticancer drug--carboquone]. Gan To Kagaku Ryoho.
1988 Mar;15(3):549-54. Review. Japanese. PubMed PMID: 3279914.
110: Maehara Y, Kusumoto H, Anai H, Kusumoto T, Sugimachi K. New
cytoskeletal proteins are induced in HeLa cells by Vinca alkaloids.
Oncology. 1988;45(3):187-91. PubMed PMID: 3130596.
111: Maehara Y, Anai H, Kusumoto H, Kusumoto T, Sugimachi K. Colorectal
carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil
compared with six other antitumor drugs: carboquone, Adriamycin,
mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil. Dis Colon
Rectum. 1988 Jan;31(1):62-7. PubMed PMID: 3130239.
112: Koga T, Nakarai I, Rikitake H, Shinoda A. [A case of relapsed
pulmonary carcinoma showing an interesting chemotherapeutic course]. Gan
To Kagaku Ryoho. 1987 Dec;14(12):3355-8. Japanese. PubMed PMID: 3688895.
113: Uchibayashi T, Hisazumi H, Asari T, Kobashi K, Amano T, Naito K.
[An in vitro chemosensitivity study using the human tumor clonogenic
assay in urological malignancies: a preliminary report]. Hinyokika Kiyo.
1987 Oct;33(10):1575-80. Japanese. PubMed PMID: 3445845.
114: Kobayashi N. [Experimental and clinical study of a new embolic
material in the treatment of malignant tumor--gelatin sponge containing
carboquone]. Nippon Igaku Hoshasen Gakkai Zasshi. 1987 Sep
25;47(9):1127-44. Japanese. PubMed PMID: 3432057.
115: Ichihashi H, Kondo T, Nakazato H. [Clinical results of a randomized
controlled trial on the effect of adjuvant immunochemotherapy using
Esquinon and Krestin in patients with curatively resected gastric
cancer--7-year survival--Cooperative Study Group for Cancer
Immunochemotherapy, Tokai Gastrointestinal Oncology Group]. Gan To
Kagaku Ryoho. 1987 Sep;14(9):2758-66. Japanese. PubMed PMID: 3307635.
116: Tari K, Satake I, Kojima S, Negishi T, Yoshida K, Nakame Y, Kanaoya
F, Horiuchi S, Saito T, Owada F, et al. [Prophylactic intravesical
chemotherapy in bladder tumors after surgery of upper tract urothelial
carcinoma]. Hinyokika Kiyo. 1987 Jun;33(6):852-6. Japanese. PubMed PMID:
3118664.
117: Maehara Y, Anai H, Kusumoto H, Sugimachi K. Poorly differentiated
human gastric carcinoma is more sensitive to antitumor drugs than is
well differentiated carcinoma. Eur J Surg Oncol. 1987 Jun;13(3):203-6.
PubMed PMID: 3036603.
118: Baba T, Taniguchi S. [Improvement of cancer therapy by angiotensin
II-induced hypertension chemotherapy]. Gan To Kagaku Ryoho. 1987
Mar;14(3 Pt 2):971-7. Japanese. PubMed PMID: 3566298.
119: Hoshino S, Saito H, Wada M, Akutsu M, Shiozaki H, Takanashi M,
Takei Y, Tanaka S, Teramura M, Takada K, et al. [Comparative studies of
intermittent melphalan and prednisolone (MP) versus 5-drug regimen
(QUVMP) and 3-drug regimen (QUP) in multiple myeloma]. Rinsho Ketsueki.
1987 Mar;28(3):358-65. Japanese. PubMed PMID: 3475485.
120: Nakajima K, Hisazumi H. Enhanced radioinduced cytotoxicity of
cultured human bladder cancer cells using 43 degrees C hyperthermia or
anticancer drugs. Urol Res. 1987;15(5):255-60. PubMed PMID: 3686753.
121: Maehara Y, Anai H, Kusumoto H, Sugimachi K. Carboquone alters the
protein synthesis of Chinese hamster V79 cell. Oncology.
1987;44(4):253-6. PubMed PMID: 3614815.
122: Konami T. [Experimental study of chemotherapy of renal cell
carcinoma. 1. Combination effect through the use of cell
kinetics-directed treatment schedules]. Hinyokika Kiyo. 1987
Jan;33(1):1-14. Japanese. PubMed PMID: 3577958.
123: Saito T. [Influence of cell growth inhibitors on the eruption rate
using the soft X-ray photographic method]. Shoni Shikagaku Zasshi.
1987;25(1):54-61. Japanese. PubMed PMID: 3506299.
124: Babaya K, Takahashi S, Momose H, Matsuki H, Sasaki K, Samma S,
Ozono S, Hirao Y, Okajima E. Effects of single chemotherapeutic agents
on development of urinary bladder tumor induced by
N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats. Urol Res.
1987;15(6):329-34. PubMed PMID: 3433593.
125: Shiraishi A, Katayama T, Matsuda T, Itoh Y, Haneishi T. Effects of
a new antibiotic, isohematinic acid, on the resistance of mice to
experimental infections. Microbiol Immunol. 1987;31(5):461-8. PubMed
PMID: 3309579.
126: Yagita A, Orima I, Okada N, Ootsuka S, Oda T, Takeuchi N, Hosaka N,
Matsumoto H, Itoh H, Ono M, et al. [A case report of patient with
advanced stomach carcinoma of linitis plastica type responding to
multi-immunotherapy and chemotherapy]. Gan To Kagaku Ryoho. 1987
Jan;14(1):196-9. Japanese. PubMed PMID: 3026254.
127: Naito K, Hisazumi H, Mihara S, Asari T, Kobashi K, Amano T,
Uchibayashi T. Chemosensitivity study of urological malignancies using a
novel dye-exclusion method. Cancer Chemother Pharmacol. 1987;20
Suppl:S1-5. PubMed PMID: 2822275.
128: Naito K, Hisazumi H, Asari T, Kobashi K, Amano T, Uchibayashi T.
[An in vitro chemosensitivity study using human tumor clonogenic assay
in urologic malignancies]. Hinyokika Kiyo. 1986 Dec;32(12):1959-66.
Japanese. PubMed PMID: 3825833.
129: Kato T, Takamoto S, Ota K. [Antitumor effect of
1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5- diphoshorine-1-oxide].
Gan To Kagaku Ryoho. 1986 Dec;13(12):3401-7. Japanese. PubMed PMID:
3789752.
130: Nagamatsu Y, Nakarai I, Matsuo T, Kawahara M, Shinoda A. [A case of
relapsed gastric cancer treated successfully by chemotherapy--lung
metastasis and relapsed cancer in the hepatic portal system]. Gan To
Kagaku Ryoho. 1986 Dec;13(12):3527-31. Japanese. PubMed PMID: 3098184.
131: Nakarai I, Ueno T, Hayashi A, Shinoda A. [Combination therapy of
high-dose carboquone and OK-432 in unresectable non-small cell lung
cancer]. Gan To Kagaku Ryoho. 1986 Dec;13(12):3508-12. Japanese. PubMed
PMID: 3024582.
132: Osawa T. [Chemotherapy of renal cell carcinoma. II. Adriamycin and
carboquone combined chemotherapy]. Nippon Hinyokika Gakkai Zasshi. 1986
Nov;77(11):1805-13. Japanese. PubMed PMID: 3573463.
133: Tanaka T, Yuasa M, Yamamoto A, Kawanishi Y, Numata A, Imagawa A.
[Oral administration of 5-fluorouracil (5-FU) with intravesical
chemotherapy as prophylaxis against recurrence of superficial bladder
tumors]. Gan No Rinsho. 1986 Sep;32(11):1439-42. Japanese. PubMed PMID:
3773272.
134: Anai H, Maehara Y, Kusumoto H, Masuda H, Miyamoto K, Fukuchi K,
Tamada R, Sugimachi K. [In vitro chemosensitivity of various human
tumors evaluated by the succinate dehydrogenase inhibition (SDI) test
(2)]. Gan To Kagaku Ryoho. 1986 Aug;13(8):2544-8. Japanese. PubMed PMID:
3740857.
135: Komiyama T, Kikuchi T, Sugiura Y. Interactions of anticancer
quinone drugs, aclacinomycin A, adriamycin, carbazilquinone, and
mitomycin C, with NADPH-cytochrome P-450 reductase, xanthine oxidase and
oxygen. J Pharmacobiodyn. 1986 Aug;9(8):651-64. PubMed PMID: 3023600.
136: Koike K. [Experimental combination chemotherapy with carboquone and
5-fluorouracil of human germ cell tumors transplanted into nude mice].
Nippon Gan Chiryo Gakkai Shi. 1986 Jul 20;21(6):1302-10. Japanese.
PubMed PMID: 3023505.
137: Maru A, Nantani M, Koyanagi T, Ohashi N, Yamada T, Fujieda J, Omuro
H, Nishida T, Kusakai Y, Amino I, et al. [Prophylactic chemotherapy of
transitional cell carcinoma of the bladder: the efficacy of long-term
bladder instillation]. Nippon Hinyokika Gakkai Zasshi. 1986
Jul;77(7):1089-98. Japanese. PubMed PMID: 3784197.
138: Maehara Y, Anai H, Masuda H, Miyamoto K, Fukuchi K, Tamada R,
Sugimachi K. [In vitro chemosensitivity testing evaluated by
intracellular ATP level: ATP assay]. Gan To Kagaku Ryoho. 1986
Jul;13(7):2342-5. Japanese. PubMed PMID: 3729490.
139: Nio Y, Ohgaki K, Inamoto T, Kan N, Kodama H, Tobe T. [An in vitro
sensitivity assay for anti-cancer agents by measuring the inhibition
rate of DNA synthesis (3H-thymidine uptake of cancer cells). II.
Clinical study of 110 cases of breast cancer]. Nippon Geka Gakkai Zasshi.
1986 Jun;87(6):680-96. Japanese. PubMed PMID: 3016495.
140: Ichihashi H, Akiyama S, Takagi H. Correlation of an in vitro
chemosensitivity test using [3H] incorporation with the response in case
of human tumor chemotherapy. Jpn J Surg. 1986 May;16(3):195-201. PubMed
PMID: 3090333.
141: Niikura H. [Thrombosis in various diseases: myeloproliferative
disorders]. Nippon Rinsho. 1986 May;44(5):1144-52. Review. Japanese.
PubMed PMID: 2943916.
142: Ichihashi H. [Clinical application of chemosensitivity testing
using radioactive precursors]. Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt
2):1156-62. Japanese. PubMed PMID: 3729437.
143: Kusai A, Ueda S. The stability of carboquone in alcohols. II.
Kinetics and mechanisms of degradation of carboquone in methanol. Chem
Pharm Bull (Tokyo). 1986 Mar;34(3):1299-308. PubMed PMID: 3731347.
144: Takahagi H, Inoue K, Horiguchi M. Drug monitoring by a fully
automated high-performance liquid chromatographic technique, involving
direct injection of plasma. J Chromatogr. 1986 Feb 21;352:369-79. PubMed
PMID: 3457796.
145: Nakazato H, Ichihashi H, Kondo T. [Clinical results of a randomized
controlled trial on the effect of adjuvant immunochemotherapy using
Esquinon and Krestin in patients with curatively resected gastric
cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai
Gastrointestinal Oncology Group]. Gan To Kagaku Ryoho. 1986
Feb;13(2):308-18. Japanese. PubMed PMID: 3947108.
146: Sugawa T, Yamagata S. [Differing progress patterns in cancer of the
uterine cervix and variant effects of adjuvant chemotherapy based on
histological type]. Gan To Kagaku Ryoho. 1986 Feb;13(2):210-5. Japanese.
PubMed PMID: 3080962.
147: Nakagami Y, Kishimoto T, Matsumoto K. [Experimental study on
immunochemotherapy (PSK, CQ) in rat bladder cancer (BC-47)]. Gan To
Kagaku Ryoho. 1985 Oct;12(10):1968-74. Japanese. PubMed PMID: 4051512.
148: Shinkai T, Saijo N, Yoshioka S, Suemasu K, Hasegawa H, Miyazawa N,
Kamiya T, Kanzawa F, Nakajima T, Shimosato Y. Recurrence of thymoma with
appearance of myasthenia gravis 18 years after surgery: a case report.
Jpn J Clin Oncol. 1985 Sep;15(3):567-75. PubMed PMID: 4057633.
149: Kawano S, Kubota M, Tanaka K, Ogawa H. [Experience of
intra-arterial chemotherapy for advanced bladder cancer with antitumor
agents]. Nippon Hinyokika Gakkai Zasshi. 1985 Sep;76(9):1393-400.
Japanese. PubMed PMID: 3936961.
150: Okada J, Kusai A, Ueda S. Core treatment for improving
microencapsulability in simple gelatin coacervation method. J
Microencapsul. 1985 Jul-Sep;2(3):175-82. PubMed PMID: 3880484.
151: Carmichael AJ, Samuni A, Riesz P. Photogeneration of superoxide and
decarboxylated peptide radicals by carboquone, mitomycin C and
streptonigrin. An electron spin resonance and spin trapping study.
Photochem Photobiol. 1985 Jun;41(6):635-42. PubMed PMID: 2991956.
152: Fujiya S, Yasuda M, Tahira K, Nakabayashi Y, Yoshioka M, Terashima
Y, Hatiya S. [In vitro sensitivity test of a cultured human ovarian
cancer cell line to anticancer agents]. Gan To Kagaku Ryoho. 1985
May;12(5):1080-7. Japanese. PubMed PMID: 3922310.
153: Komiyama T, Sawada MT, Kobayashi K, Yoshimoto A. Enhanced
production of ethylene from methional by iron chelates and heme
containing proteins in the system consisting of quinone compounds and
NADPH-cytochrome P-450 reductase. Biochem Pharmacol. 1985 Apr
1;34(7):977-83. PubMed PMID: 3921033.
154: Ishikawa S, Hayashi K, Ree T, Saotome K, Yanai N, Iriki A, Kimura
S, Hirata M, Nishiyama Y, Kawamura M, et al. [Long-term results of the
pulmonary resection with and without combined antineoplastic agents for
primary bronchogenic carcinoma]. Kyobu Geka. 1985 Feb;38(2):113-7.
Japanese. PubMed PMID: 3921745.
155: Mickey DD. Combined therapeutic effects of an immunomodulator, PSK,
and chemotherapy with carboquone on rat bladder carcinoma. Cancer
Chemother Pharmacol. 1985;15(1):54-8. PubMed PMID: 4006049.
156: Nio Y, Inamoto T, Ohgaki K, Kan N, Hori T, Nakayama N, Yamasaki N,
Hikasa Y. [An in vitro sensitivity assay of anti-cancer agents by
measuring the inhibition rate of DNA synthesis (3H-thymidine uptake) of
cancer cells--clinical study]. Nippon Geka Gakkai Zasshi. 1985
Jan;86(1):8-22. Japanese. PubMed PMID: 3974569.
157: Watanabe Y, Sato H, Iida S, Yamada T, Kobayashi H, Kimoto H,
Tsunamura Y, Ichihashi T, Shimizu J, Hashizume Y, et al. [Clinical value
of postoperative chemotherapy for non-small cell lung cancer--with
special reference to long-term combined chemotherapy combined with
immunotherapy]. Gan To Kagaku Ryoho. 1985 Jan;12(1):21-35. Japanese.
PubMed PMID: 2981515.
158: Okazaki A, Niibe H, Mitsuhashi N, Ito J, Tatezawa T, Sakaino K,
Baba T, Sakata N. [Effects of PS-K as adjuvant therapy for primary lung
cancer--an autopsy case]. Gan No Rinsho. 1984 Oct;30(13):1707-12.
Japanese. PubMed PMID: 6513025.
159: Fukuma H, Beppu Y, Nishikawa K. [Adjuvant chemotherapy in the
treatment of primary soft tissue sarcomas, with special reference to
intra-arterial infusion chemotherapy]. Gan To Kagaku Ryoho. 1984
Sep;11(9):1729-35. Japanese. PubMed PMID: 6476841.
160: Mizuno H, Inomata T, Umezawa T, Shimizu F, Arakawa M. [Antitumor
effect of FU-O-G, new antitumor agent, following long term
administration]. Gan To Kagaku Ryoho. 1984 Sep;11(9):1848-54. Japanese.
PubMed PMID: 6433807.
161: Nishi Y, Hasegawa MM, Taketomi M, Ohkawa Y, Inui N. Comparison of
6-thioguanine-resistant mutation and sister chromatid exchanges in
Chinese hamster V79 cells with forty chemical and physical agents.
Cancer Res. 1984 Aug;44(8):3270-9. PubMed PMID: 6744262.
162: Ohmori H. [Intravesical chemotherapy for superficial bladder
tumors]. Gan To Kagaku Ryoho. 1984 Aug;11(8):1557-62. Japanese. PubMed
PMID: 6206797.
163: Fukuoka M, Takada M, Tamai S, Negoro S, Matsui K, Ryu S, Sakai N,
Sakaguchi K. [Local application of anti-cancer drugs for the treatment
of malignant pleural and pericardial effusion]. Gan To Kagaku Ryoho.
1984 Aug;11(8):1543-9. Japanese. PubMed PMID: 6206796.
164: Ninomiya K, Sekido S, Araki T. [Effect of combination chemotherapy
of nitrosourea MCNU with various anti-tumor agents]. Gan To Kagaku Ryoho.
1984 Jun;11(6):1315-23. Japanese. PubMed PMID: 6428326.
165: Kakizoe T, Matsumoto K, Nishio Y, Ohtani M, Miyazawa N.
Chemotherapy by bronchial arterial infusion for pulmonary metastases of
renal cell carcinoma. J Urol. 1984 Jun;131(6):1053-5. PubMed PMID:
6427476.
166: Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Takahashi K,
Sasaki Y, Ohkura H. [The value of carcinoembryonic antigens in patients
with advanced lung cancer: in relation to chemotherapy]. Gan To Kagaku
Ryoho. 1984 May;11(5):1056-63. Japanese. PubMed PMID: 6202246.
167: Yoshikawa H, Sao H, Tahara T, Akao Y, Yoshikawa S. [A case of
refractory acute lymphocytic leukemia who achieved a complete remission
by mitoxantrone]. Gan To Kagaku Ryoho. 1984 Mar;11(3):515-20. Japanese.
PubMed PMID: 6584088.
168: Wakui A, Sato H. [Clinical studies on induced hypertension
chemotherapy based on functional characteristics of microcirculation of
tumor vessels]. Gan To Kagaku Ryoho. 1984 Mar;11(3 Pt 2):741-9.
Japanese. PubMed PMID: 6424580.
169: Ohkawa K, Tsukada Y, Hirai H. [Effect of antibody to rat
alpha-fetoprotein (AFP) on protein and DNA synthesis of rat ascites
hepatoma AH66 cells]. Gan To Kagaku Ryoho. 1984 Feb;11(2):227-34.
Japanese. PubMed PMID: 6198967.
170: Maeyama M, Tayama C, Inoue S, Tajima C, Onizuka Y, Tanaka N,
Nakayama M, Iwamasa T. Serial serum determination on alpha-fetoprotein
as a marker of the effect of postoperative chemotherapy in ovarian
endodermal sinus tumor. Gynecol Oncol. 1984 Jan;17(1):104-16. PubMed
PMID: 6198243.
171: Himori T, Wakui A, Saito T. Clinical evaluation of anticancer
alkylating agent, carboquone (NSG-134679). Sci Rep Res Inst Tohoku Univ
Med. 1983 Dec;30(1-4):92-9. PubMed PMID: 6678502.
172: Uchibayashi T, Hisazumi H, Saitoh Y, Naitoh K, Misaki T, Nango C,
Tajiri S, Nakamura T, Kojima A, Mikawa I. [Combination chemotherapy with
adriamycin, carboquone and 5-Fu for bladder cancer]. Hinyokika Kiyo.
1983 Dec;29(12):1617-23. Japanese. PubMed PMID: 6677109.
173: Nakata H. [Experimental combination chemotherapy with vincristine
and carboquone in human ovarian cancer transplanted into nude mice].
Nippon Sanka Fujinka Gakkai Zasshi. 1983 Nov;35(11):1991-8. Japanese.
PubMed PMID: 6663131.
174: Yamanaka H, Kaburagi Y, Imai K, Miki M. [Experimental and clinical
studies on intravesical instillation therapy for bladder cancer].
Hinyokika Kiyo. 1983 Nov;29(11):1427-32. Japanese. PubMed PMID: 6428193.
175: Takai K, Moriyama N, Shinohara M, Fukutani K, Mikata N, Yokoyama M,
Kogure T. [Synchronous double cancer of the esophagus and the urinary
bladder: report of two cases]. Hinyokika Kiyo. 1983 Sep;29(9):1085-9.
Japanese. PubMed PMID: 6677142.
176: Okajima E, Ijuin M, Hiramatsu T, Kihoin K, Hirao Y, Ohara S,
Hijioka T, Babaya K, Shiomi T, Samma S, et al. [Fundamental studies on
intravesical instillation of carboquone for treatment of urinary bladder
tumors--on the effects of intravesical instillation of carboquone in
normal beagle dogs]. Hinyokika Kiyo. 1983 Sep;29(9):1061-74. Japanese.
PubMed PMID: 6428197.
177: Uchibayashi T. [Chemosensitivity in established human bladder
carcinoma and HELA cell lines in vitro]. Nippon Hinyokika Gakkai Zasshi.
1983 Sep;74(9):1606-20. Japanese. PubMed PMID: 6202921.
178: Yoh S, Takagishi N, Iwasaki H, Eimoto T, Ono Y, Okasaki M. [Intraarterial
high-dose adriamycin for patients with skeletal or soft tissue sarcoma].
Gan No Rinsho. 1983 Aug;29(10):1263-73. Japanese. PubMed PMID: 6632206.
179: Wakui A, Suzuki M. [Cancer chemotherapy in combination with
angiotensin-induced hypertension]. Gan To Kagaku Ryoho. 1983
Jul;10(7):1577-83. Japanese. PubMed PMID: 6409008.
180: Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Shibuya M,
Shimabukuro Z, Koketsu H, Nakajima T, Niitani H. Pulmonary toxicity
induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Jpn J Clin Oncol. 1983 Jun;13(2):395-410. PubMed PMID: 6193296.
181: Kojima J, Kamada T, Monna J. [Clinical study on combination
chemotherapy of primary liver cancer]. Gan To Kagaku Ryoho. 1983
Apr;10(4 Pt 1):997-1006. Japanese. PubMed PMID: 6408995.
182: Saijo N, Shimizu E, Eguchi K, Shinkai T, Tominaga K, Shibuya M,
Shimabukuro Z, Niitani H, Hoshi A. Effect of peplomycin plus
carbazilquinone and mitomycin on non-small cell carcinoma of the lung.
Cancer Treat Rep. 1983 Apr;67(4):385-7. PubMed PMID: 6189601.
183: Ueda Y, Saito A, Fukuoka Y, Yamashiro Y, Ikeda Y, Taki H, Yasuda T,
Saikawa I. Interactions of beta-lactam antibiotics and antineoplastic
agents. Antimicrob Agents Chemother. 1983 Mar;23(3):374-8. PubMed PMID:
6405686; PubMed Central PMCID: PMC184655.
184: Yoshida O, Miyakawa M, Watanabe H, Mishina T, Kobayashi T, Nakagawa
K, Fukuyama T, Ogura K, Ueyama H, Itoh H, et al. [Study of combination
chemotherapy with cytosine arabinoside in the intravesical treatment of
superficial bladder tumors]. Hinyokika Kiyo. 1983 Mar;29(3):357-64.
Japanese. PubMed PMID: 6233856.
185: Moriyama M, Kubota Y, Miura T, Shuin T, Noguchi S. [The effect of
intravesical chemotherapy on superficial urinary bladder cancer].
Hinyokika Kiyo. 1983 Mar;29(3):351-5. Japanese. PubMed PMID: 6203382.
186: Hisazumi H, Nakajima K, Uchibayashi T. Chemosensitivity of
established human bladder carcinoma cell lines in vitro. Gann. 1983
Feb;74(1):176-82. PubMed PMID: 6840436.
187: Nakagami Y, Minowa T, Tozuka K, Hiraoka Y, Chin H. Evaluation of
multidisciplinary treatment of bladder cancer, especially in
chemoimmunotherapy (ADM and OK-432) as a consolidation therapy. Cancer
Chemother Pharmacol. 1983;11 Suppl:S47-50. PubMed PMID: 6605813.
188: Himori T, Ujiie S, Mimata Y, Sugiyama Z, Wakui A. Total tumor cell
count and hematopoietic system of ah 109A-bearing rats treated with
mitomycin C and carboquone. Sci Rep Res Inst Tohoku Univ Med. 1982
Dec;29(1-4):77-86. PubMed PMID: 6308758.
189: Monna T, Kanno T, Marumo T, Harihara S, Kuroki T, Yamamoto S,
Kobayashi N, Sato M, Nakamura K, Nakatsuka H, Onoyama Y, Yamada R. A
comparison of transcatheter arterial embolization with one shot therapy
for the patients with hepatic cell carcinoma. Gastroenterol Jpn. 1982
Dec;17(6):542-9. PubMed PMID: 6298047.
190: Komiyama T, Kikuchi T, Sugiura Y. Generation of hydroxyl radical by
anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A
and adriamycin, in the presence of NADPH-cytochrome P-450 reductase.
Biochem Pharmacol. 1982 Nov 15;31(22):3651-6. PubMed PMID: 6295407.
191: Tsukada K, Okada R, Hisaoka M, Morioka T. Liposome-encapsulated
carboquone. I. Method of preparation and carboquone release. Chem Pharm
Bull (Tokyo). 1982 Oct;30(10):3679-84. PubMed PMID: 7160014.
192: Uzuka Y, Saito Y, Takahashi H, Komatsu M. Carboquone therapy for
hematologic neoplasms. Tohoku J Exp Med. 1982 Oct;138(2):151-60. PubMed
PMID: 6960553.
193: Saijo N, Shimizu E, Shibuya M, Irimajiri N, Takizawa T, Eguchi K,
Shinkai T, Tominaga K, Shimabukuro Z, Taniguchi T, Hoshi A. Effect of
chemotherapy on natural-killer activity and antibody-dependent
cell-mediated cytotoxicity in carcinoma of the lung. Br J Cancer. 1982
Aug;46(2):180-9. PubMed PMID: 6185128; PubMed Central PMCID: PMC2011091.
194: Nakarai I, Honda T, Jinnai S, Kita T, Shinoda A. [Combination
therapy of large amount of carboquone and OK-432 for unresectable lung
cancer]. Gan To Kagaku Ryoho. 1982 Jul;9(6):1006-11. Japanese. PubMed
PMID: 7184436.
195: Inoue S, Fukuda O, Tajima C, Tokunaga T, Nakayama M, Maeyama M.
[Combined administration of futraful and esquinone for the treatment of
advanced ovarian cancer]. Gan To Kagaku Ryoho. 1982 Jul;9(7):1226-30.
Japanese. PubMed PMID: 6820911.
196: Saijo N. [Chemotherapy against pulmonary metastasis from uterine
cervical carcinoma]. Gan To Kagaku Ryoho. 1982 Jul;9(6):992-7. Japanese.
PubMed PMID: 6191708.
197: Masuda H, Sumiyoshi Y, Shiojima Y, Kikyo T, Fujiyama N, Iwata M,
Machida Y, Nagai K. Local therapy of carcinoma of the uterine body (1st
report). Asia Oceania J Obstet Gynaecol. 1982 Jun;8(2):117-26. PubMed
PMID: 6182870.
198: Okajima E, Hiramatsu T, Okamoto M, Kihoin K, Ijuin M, Hirao Y,
Ohara S, Babaya K, Kubota K, Samma S, Okamura K, Kaneko Y, Horii Y,
Moriya A. [Effect of carboquone (esquinone) on the development of
urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)
nitrosamine]. Gan To Kagaku Ryoho. 1982 May;9(5):836-42. Japanese.
PubMed PMID: 7184430.
199: Katoh T, Ishige H, Takamizawa H, Tokita H, Tanaka N. [Effects of
various agents on human choriocarcinoma transplanted to nude mice]. Gan
To Kagaku Ryoho. 1982 May;9(5):843-8. Japanese. PubMed PMID: 6892200.
200: Sekiya S, Iwasawa H, Takamizawa H. [Maintenance chemotherapy for
ovarian adenocarcinoma with carboquone: doses and side effects (author's
transl)]. Nippon Sanka Fujinka Gakkai Zasshi. 1982 May;34(5):634-6.
Japanese. PubMed PMID: 6282997.
201: Hisaoka M, Morioka T, Yagita A. Determination of carboquone in
plasma and ascites by high performance liquid chromatography after
intravenous and intraperitoneal administration in man. Gann. 1982
Apr;73(2):161-6. PubMed PMID: 7117751.
202: Yokoyama K, Kaito S, Sobajima T, Fukumoto H, Horiguchi Y, Takeuchi
A, Kurokawa A. [Effects of pepleomycin (PEP) infused through bronchial
artery for lung cancer: in comparison with the cases of mitomycin (MMC)
or carboquon (CQ)]. Gan To Kagaku Ryoho. 1982 Apr;9(4):688-93. Japanese.
PubMed PMID: 6191702.
203: Shinkai K, Arakawa M. [Effect of carboquone in complete regression
of mouse mammary cancer MM-46]. Gan To Kagaku Ryoho. 1982
Mar;9(3):556-7. Japanese. PubMed PMID: 7184412.
204: Matsumura Y. [Intravesical instillation of adriamycin and other
antineoplastic agents]. Gan To Kagaku Ryoho. 1982 Mar;9(3):372-6.
Japanese. PubMed PMID: 7184406.
205: Motoyama T. [Quantitative analysis on in vitro drug sensitivity of
cultured human ovarian cancer cell lines (author's transl)]. Nippon
Sanka Fujinka Gakkai Zasshi. 1982 Mar;34(3):308-14. Japanese. PubMed
PMID: 7069245.
206: Negoro S, Fukuoka M, Takada M, Tamai S, Sakai N, Matsui K.
[Combination chemotherapy with peplomycin and carboquone (esquinon) for
squamous cell carcinoma of the lung]. Gan To Kagaku Ryoho. 1982
Mar;9(3):522-8. Japanese. PubMed PMID: 6191699.
207: Yajima A, Mori T, Wakisaka T, Sato S, Sakahira H, Yamauchi R,
Suzuki M. FQC combination chemotherapy for primary malignant ovarian
tumor. Gynecol Oncol. 1982 Feb;13(1):93-100. PubMed PMID: 6800893.
208: Hoshiya T, Matsunaga T, Hyo Y, Mori N, Kakiuchi H, Saeki K, Wakuda
K. [Compound therapy including PSK for malignant head and neck cancer].
Gan To Kagaku Ryoho. 1982 Jan;9(1):91-5. Japanese. PubMed PMID: 7184365.
209: Tsuya A, Kaneda K, Mikuriya S, Horiuchi J, Amino S, Mochizuki S,
Kamata R, Ikeda M, Okawa T. [Evaluation of a combined application of
radiotherapy, carboquone, and PSK in malignant tumor--clinical results
at 7 facilities]. Gan No Rinsho. 1982;28(1):49-54. Japanese. PubMed
PMID: 7182548.
210: Hisaoka M, Tsukada K, Morioka T, Inomata T, Arakawa M. Studies on
liposome-encapsulated carboquone. IV. Enhancement of antitumor activity
of carboquone against Ehrlich ascites carcinoma by encapsulation. J
Pharmacobiodyn. 1982 Jan;5(1):34-9. PubMed PMID: 7077520.
211: Hisaoka M, Tsukada K, Morioka T. Studies on liposome-encapsulated
carboquone. III. Enhancement of lymphatic transport of carboquone by
encapsulation. J Pharmacobiodyn. 1982 Jan;5(1):27-33. PubMed PMID:
7077519.
212: Hisaoka M, Tsukada K, Morioka T. Studies on liposome-encapsulated
carboquone II. Effect of liposomal encapsulation of carboquone on
distribution and clearance in animals. J Pharmacobiodyn. 1982
Jan;5(1):18-26. PubMed PMID: 7077518.
213: Sakata Y, Yoshida Y, Komatsu Y, Sugawara K, Nishimura S, Kikuchi K.
[MQF-OK therapy in advanced terminal stomach cancer--with special
reference to a comparison with MFC therapy]. Gan To Kagaku Ryoho. 1982
Jan;9(1):109-15. Japanese. PubMed PMID: 6820875.
214: Sugimori H, Kidera Y, Matsuyama T. [Combined chemotherapy of
ovarian cancer with special reference to carboquone]. Gan To Kagaku
Ryoho. 1982 Jan;9(1):66-71. Japanese. PubMed PMID: 6307172.
215: Niikura H, Hagiwara S, Nishiyama H, Mori H, Mohri H, Matsuno K,
Terada H. [Therapy of polycythemia vera and essential thrombocythemia
with carboquone (author's transl)]. Rinsho Ketsueki. 1981
Nov;22(11):1700-7. Japanese. PubMed PMID: 7339013.
216: Masuda H, Sumiyoshi Y, Shiojima Y, Suda T, Kikyo T, Iwata M,
Fujiyama N, Machida Y, Nagai K. Local therapy of carcinoma of the
uterine cervix: part I. Cancer. 1981 Oct 15;48(8):1899-906. PubMed PMID:
6169425.
217: Goto M, Mitsuoka A, Sugiyama M, Kitano M. Enhancement of delayed
hypersensitivity reaction with varieties of anti-cancer drugs. A common
biological phenomenon. J Exp Med. 1981 Jul 1;154(1):204-9. PubMed PMID:
6788892; PubMed Central PMCID: PMC2186397.
218: Kikuchi T, Sugiura Y, Komiyama T. Generation of semiquinone radical
from carbazilquinone by NADPH-cytochrome P-450 reductase. Biochem
Pharmacol. 1981 Jun 15;30(12):1717-8. PubMed PMID: 6268108.
219: Taniguchi S, Kimura NT, Baba T. Effects of pH on cytotoxicity of
carboquone. Jpn J Pharmacol. 1981 Apr;31(2):243-7. PubMed PMID: 7311142.
220: Kondo T, Sakamoto J, Ichihashi H, Kamei H. Effect of alternating
administration of PS-K and carbazilquinone in tumor-bearing mice. Gann.
1981 Apr;72(2):293-9. PubMed PMID: 7286551.
221: Itami M, Yamada R, Nakatsuka H, Nakamura K, Sato M, Kobayashi N,
Takashima S, Minakuchi K, Yamashita A, Onoyama Y. [New embolic material
for therapeutic embolization of malignant tumor--gelatin sponge
containing carbazilquinone (author's transl)]. Nippon Igaku Hoshasen
Gakkai Zasshi. 1981 Jan 25;41(1):75-8. Japanese. PubMed PMID: 7232114.
222: Hisazumi H, Uchibayashi T, Katoh M, Kobayashi T, Nakajima K, Naitoh
K, Misaki T, Kuroda K. Anticancer drug sensitivity in vitro in the
bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone
and urokinase in bladder cancer. Urol Res. 1981;9(5):231-5. PubMed PMID:
7029855.
223: Arai T, Takahashi K, Ishiguro K, Mikami Y. Some chemotherapeutic
properties of two new antitumor antibiotics, saframycins A and C. Gann.
1980 Dec;71(6):790-6. PubMed PMID: 7274625.
224: Sawada M, Hayakawa K, Matsui Y, Nishiura H, Okudaira Y.
[Chemotherapy of yolk sac tumor heterotransplanted to nude mice
(author's transl)]. Nippon Sanka Fujinka Gakkai Zasshi. 1980
Oct;32(10):1596-602. Japanese. PubMed PMID: 7240825.
225: Yajima A, Higashiiwai H, Sato A, Watanabe M, Mori T, Suzuki M,
Hanyu T, Suzuki K, Kinii H, Moritsuka T, Igarashi N, Nakano M, Nagasawa
K, Sato S. Combination chemotherapy in advanced ovarian cancer. Tohoku J
Exp Med. 1980 Oct;132(2):225-9. PubMed PMID: 6777904.
226: Mizuno S, Amagai M, Ishida A. Synergistic cell killing by antitumor
agents and hyperthermia in cultured cells. Gann. 1980 Aug;71(4):471-8.
PubMed PMID: 6159245.
227: Uehara N, Shirakawa S, Uchino H, Saeki Y, Nozaki M. Elevated
polyamine levels in erythrocytes of SLC:ICR mice inoculated with Ehrlich
ascites carcinoma cells. Life Sci. 1980 Feb 11;26(6):461-7. PubMed PMID:
7374356.
228: Machida Y, Masuda H, Fujiyama N, Iwata M, Nagai T. Preparation and
phase II clinical examination of topical dosage forms for the treatment
of carcinoma colli containing bleomycin, carboquone, or 5-fluorouracil
with hydroxypropyl cellulose. Chem Pharm Bull (Tokyo).
1980;28(4):1125-30. PubMed PMID: 6158378.
229: Miyamoto T. Recent results of using a sequential combination of
bleomycin and mitomycin C in the treatment of metastatic cervical
cancer. Recent Results Cancer Res. 1980;70:211-7. PubMed PMID: 6153471.
230: Kamura T, Aoki K, Nishikawa K, Baba T. Antitumor effect of
thermodifferential chemotherapy with carboquone on Ehrlich carcinoma.
Gann. 1979 Dec;70(6):783-90. PubMed PMID: 535687.
231: Hashimoto R, Yamazaki Y, Shiozaki K, Akai S, Shimada K, Sato M,
Kurita Y, Hirono T, Sato Y. [An operated case of the lung cancer
associated with the esophageal necrosis due to the bronchial artery
infusion (author's transl)]. Kyobu Geka. 1979 Nov;32(11):862-5.
Japanese. PubMed PMID: 513385.
232: Sakata Y, Sugawara K, Komatsu Y, Yoshida Y, Nishimura S, Kikuchi K.
[Combination chemotherapy of mitomycin-C, carboquone, 5-fluorouracil and
OK-432 for inoperable gastric cancer (author's transl)]. Nippon Gan
Chiryo Gakkai Shi. 1979 Oct 20;14(6):978-87. Japanese. PubMed PMID:
541534.
233: Kato T, Nemoto R, Nishimoto T, Kumagai I, Miura K. Chemosensitivity
of human bladder cancer cells in long-term culture and clinical
responses to the selected anticancer drug. Cancer. 1979 Jul;44(1):58-63.
PubMed PMID: 455264.
234: Misawa S, Sawai K, Takino T, Masuda M, Abe T, Kawai K. Clinical
studies on the combined immunochemotherapy with a streptococcal
preparation (Picibanil) and other anticancer drugs. Nippon Gan Chiryo
Gakkai Shi. 1979 Jun 20;14(3):291-305. PubMed PMID: 479655.
235: Baba T, Aoki K, Kimura NT, Kamura T, Nishikawa K, Taniguchi S.
Potentiation of anticancer effect of carboquone in vivo by glucose
pretreatment. Gann. 1979 Apr;70(2):255-8. PubMed PMID: 467889.
236: Tsukeda H, Mizuno S, Nitta K. Susceptibilities of normal and
malignant human lung cells in culture to the cytocidal action of
antitumor agents. Cancer Res. 1978 Aug;38(8):2529-32. PubMed PMID:
149590.
237: Seino Y, Nagao M, Yahagi T, Hoshi A, Kawachi T, Sugimura T.
Mutagenicity of several classes of antitumor agents to Salmonella
typhimurium TA98, TA100, and TA92. Cancer Res. 1978 Jul;38(7):2148-56.
PubMed PMID: 350383.
238: Kanamaru R, Asamura M, Hayashi Y, Sato H, Saito T. Damage of DNA
and its recovery in AH-109A cells treated with carboquone in vivo.
Tohoku J Exp Med. 1978 Apr;124(4):331-7. PubMed PMID: 663931.
239: Kidera Y, Baba T. Blood flow-interrupting hyperthermic chemotherapy
on established autochthonous mouse sarcoma induced by
3-methylcholanthrene. Cancer Res. 1978 Mar;38(3):556-9. PubMed PMID:
626960.
240: Sakurai Y. Synthetic analogs of antitumor drugs under development
in Japan. Recent Results Cancer Res. 1978;63:272-81. PubMed PMID:
705011.
241: Ogawa M. A recent overview of chemotherapy for advanced stomach
cancer in Japan. Antibiot Chemother. 1978;24:149-59. Review. PubMed
PMID: 350134.
242: Wakabayashi Y, Takaku F. [Studies of carboquone therapy on chronic
myelogenous leukemia (author's transl)]. Rinsho Ketsueki. 1978
Jan;19(1):9-14. Japanese. PubMed PMID: 273114.
243: Mori T, Kayama T, Katakura R. [Medulloblastoma with intractable
ascites treated by carboquone--a complication of a ventriculoperitoneal
shunt (author's transl)]. No Shinkei Geka. 1977 Nov;5(12):1299-303.
Japanese. PubMed PMID: 593523.
244: Fujimoto S, Inagaki J, Horikoshi N, Hoshino A. Combination
chemotherapy of 6-thioguanine with various antitumor agents against
murine leukemia L-1210. Gann. 1977 Oct;68(5):543-52. PubMed PMID:
201534.
245: Sato S, Iwaizumi M, Handa K, Tamura Y. Electron spin resonance
study on the mode of generation of free radicals of daunomycin,
adriamycin, and carboquone in NAD(P)H-microsome system. Gann. 1977
Oct;68(5):603-8. PubMed PMID: 22473.
246: Iigo M, Kanzawa F, Nakamura A, Hoshi A, Kuretani K. Interaction of
antitumor agents including doxorubicin or daunorubicin in sarcoma-180
system. Gann. 1977 Aug;68(4):459-64. PubMed PMID: 616416.
247: Mori T, Fukawa O, Sato T, Hori S. [Regression of a recurrent
malignant glioma by combined chemoradiotherapy utilizing carboquone,
FT-207 and telecobalt--report of a case (author's transl)]. No Shinkei
Geka. 1977 Jul;5(8):865-9. Japanese. PubMed PMID: 331131.
248: Tamura Y, Sato S. Stimulation of a reconstituted, microsomal NADH
oxidase system by carboquone, a quinoid anticancer chemical. Gann. 1977
Jun;68(3):353-6. PubMed PMID: 199521.
249: Saito S, Takahashi Y, Ooshima H, Matuda G. [Chemotherapy of bladder
neoplasms--instillation of carboquone into the bladder]. Nippon Rinsho.
1977 May;35(5):1983-7. Japanese. PubMed PMID: 560545.
250: Baba T, Kimura NT, Kanematsu T, Aoki K, Kidera Y. Experiments on
thermodifferential chemotherapy with thoracotomy for blood-borne
pulmonary metastasis in rats. Gann. 1977 Apr;68(2):165-74. PubMed PMID:
892291.
251: Okada N, Arakawa M. Comparative studies on the antitumor effect on
intravenous administration of carbazilquinone and mitomycin-C. Gann.
1976 Dec;67(6):805-12. PubMed PMID: 1021507.
252: Iigo M, Nakamura A, Hoshi A, Kuretani K. Interaction of antitumor
agents including carboquone in sarcoma-180 system. Gann. 1976
Oct;67(5):641-4. PubMed PMID: 1017581.
253: Kidera Y, Kamura T, Aoki K, Kimura M, Baba T. [Protective effects
of general hypothermia on side effects of anticancer drugs in the
"regional hyperthermic chemotherapy combined with temporary interruption
of local blood-circulation" (author's transl)]. Fukuoka Igaku Zasshi.
1976 Sep;67(9):325-30. Japanese. PubMed PMID: 1033893.
254: Handa K, Sato S. Stimulation of microsomal NADPH oxidation by
quinone group-containing anticancer chemicals. Gann. 1976
Aug;67(4):523-8. PubMed PMID: 15920.
255: Baba T, Aoki K, Kidera Y, Kimura M, Kanematsu T. Temporary
interruption of regional blood flow combined with local hyperthermia for
cancer chemotherapy. Cancer Res. 1976 Jul;36(7 PT 1):2146-52. PubMed
PMID: 58714.
256: Abe I, Sato S. Beta-glucuronidase activity of Yoshida ascites
hepatomas of different drug-sensitivity and its change after treatment
of host rats with various anticancer agents. Gann. 1976 Feb;67(1):55-65.
PubMed PMID: 57896.
257: Kanamaru R, Asamura M, Sato H, Saito T. Comparative studies of
effects of carbazilquinone and mitomycin C on DNA, RNA and protein
synthesis of Yoshida sarcoma and Yoshida ascites hepatomas. Sci Rep Res
Inst Tohoku Univ Med. 1975 Jul;22(1-2):18-24. PubMed PMID: 171766.
258: Shimizu F, Arakawa M. Effect of
3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea
hydrochloride on lymphoid leukemia L-1210. Gann. 1975 Apr;66(2):149-54.
PubMed PMID: 1150007.
259: Handa K, Sato S. Generation of free radicals of quinone
group-containing anti-cancer chemicals in NADPH-microsome system as
evidenced by initiation of sulfite oxidation. Gann. 1975 Feb;66(1):43-7.
PubMed PMID: 239881.
260: Kimura NT, Kanematsu T, Baba T. Potentiation of anticancer drug
effect by cancer cell glycosis: an in vitro experiment. Gann. 1974
Dec;65(6):513-22. PubMed PMID: 4464181.
261: Shindo H, Nambu K, Nakajima E, Kawai K. [Absorption, distribution,
excretion and metabolism of carbazilquinone; a new anti-tumor agent, in
mice (author's transl)]. Yakugaku Zasshi. 1974 Nov;94(11):1393-403.
Japanese. PubMed PMID: 4478167.
262: Fukuda K, Arakawa M, Shindo H. Ultrastructural changes induced by
carbazilquinone in L-1210 lymphocytic leukemia cells in mice. Gann. 1974
Aug;65(4):351-8. PubMed PMID: 4426479.
263: Nakamura T, Tatsumi K, Fukai M, Sasada M, Higuchi T. [Mode of
action of carbazilquinone in leukemic cells (author's transl)]. Nippon
Ketsueki Gakkai Zasshi. 1974 Apr;37(2):65-72. Japanese. PubMed PMID:
4471859.
264: Arakawa M, Okada N. Effect of carbazilquinone on leukemic cell
count in various tissues of mice bearing leukemia L-1210. Gann. 1974
Feb;65(1):21-5. PubMed PMID: 4825388.
265: Saito T, Oira S, Wakui A, Yokoyama M, Takahashi H. Clinical
experience with a new anticancer agent, carbazilquinone (NSC-134679).
Cancer Chemother Rep. 1973 Nov-Dec;57(4):447-57. PubMed PMID: 4586952.
266: Kurita S, Nishimura M, Ogawa M, Kamei Y, Ariyoshi Y. [Clinical
studies on carbazilquinone in the treatment of malignant diseases].
Nippon Gan Chiryo Gakkai Shi. 1973 Jun 20;8(2):119-27. Japanese. PubMed
PMID: 4738331.
267: Arakawa M. Complete inhibition of mouse lymphoid leukemia L-1210 by
carbazilquinone. Gann. 1972 Aug;63(4):487-9. PubMed PMID: 5081624.
268: Straus MJ, Goldin A. Increased lifespan using the priming dose
schedule design in carbazilquinone (NSC-134679) treatment of mouse
leukemia L1210. Cancer Chemother Rep. 1972 Feb;56(1):19-23. PubMed PMID:
5030804.
269: Saito T, Oira S, Wakui A, Yokoyama M, Takahashi H. [Clinical
experience with a new anticancer agent, carbazilquinone]. Gan No Rinsho.
1971 Nov;17(11):806-18. Japanese. PubMed PMID: 4947602.
270: Kurita S, Nishimura M, Ogawa M, Kamei Y, Imai K. [Chemotherapy of
malignant cancer using carbazilquinone]. Gan No Rinsho. 1971
Oct;17(10):744-9. Japanese. PubMed PMID: 5166829.
271: Arakawa M, Nakao H, Aoki T. Effect of carbazilquinone on
transplantable and primary tumors in mice. Gann. 1970 Dec;61(6):535-9.
PubMed PMID: 5499681.
272: Arakawa M, Aoki T, Nakao H. Effect of carbazilquinone on lymphoid
leukemia L-1210. Gann. 1970 Oct;61(5):485-93. PubMed PMID: 5476838.
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|